Vault Cares Network Partners With Global Alliance for Regenerative Medicine to Pioneer Advanced Healthcare Solutions
BLOOMINGTON, IL / ACCESSWIRE / April 19, 2024 / Vault Cares Network, a subsidiary of Vault Strategies, is proud to...
Month: April 2024
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Algorithm driven alerts help identify best antibiotic for patients with common infections in two 59-hospital trials, with implications to reduce...
What’s the Buzz about 4/20? Cannabis and Mental Health Canada celebrates and reflects on the recent Legislative Review of the Cannabis Act
Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - The recently released final report of the Expert Panel on the Legislative...
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
$1.25 Billion Parenteral Nutrition Bags Markets by Chamber Type, Consumer, End User – Global Forecast to 2031 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Parenteral Nutrition Bags Market by Chamber Type (Single-Chamber Bags, Dual-Chamber Bags, Multi-Chambered Bags), Consumer (Adults, Children), End User...
Three Finalists Announced for the 2024 Bloom Burton Award
Recognizing the Year's Most Significant Contributions to Canada's Innovative Healthcare IndustryToronto, Ontario--(Newsfile Corp. - April 19, 2024) - Bloom Burton...
TrackFive’s TravelNurseSource Revolutionizes Healthcare Recruiting With the Launch of QuickConnect
TravelNurseSource is set to enhance candidate matching and reduce client costs, delivering superior outcomes compared to competitors in the healthcare...
Stemtech Corporation on Track for CEO and Chairman’s Goal for Growth and Global Expansion
Industry Recognition: Stemtech Ranked Top 5% in Direct Selling by 'Business for Home'"NAPLES, FL / ACCESSWIRE / April 19, 2024...
Sunshine Biopharma’s Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching...
Nutriband Inc. Announces $8.4M Private Placement
Nutriband is targeting a 505(b)(2) NDA to the FDA for marketing approval of AVERSA™ Fentanyl in Q1 2025 ORLANDO, FL...
PharmAla Closes Private Placement and Concurrent Debt Settlement
VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:...
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors
Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business developmentMARLBOROUGH, Mass....
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023
The Company Concluded the Year With Revenue Doubling, Alongside Substantial Improvements in Gross Profit Margins and Net Income FORT LAUDERDALE,...
3Daughters Named “Startup of the Year” at BioLabs Philadelphia Investor Day 2024
MANSFIELD, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, was...
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
Joshua S. Horowitz joins Board of DirectorsAt-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc....
Preliminary Results for the Year Ended 31 December 2023
19 April 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA)...
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated...